Novo Nordisk's pricing tactics within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, declaring the stark contrast amongst U.S. costs and people in Europe and copyright.In October 2024, Novo Nordisk published a research on scientific journal Character about a novel glucose-delica… Read More